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Abstract
Introduction. Nursing documentation is an indicator 
of healthcare quality. After extensive data analysis, 
it has been shown that nursing documentation has 
become an assessment tool and a tool to change 
clinical practice. Stroke is the most significant in-
dividual cause of disability in the adult population. 
In instances of ischemic stroke, brain circulation is 
abruptly disconnected. Causes of this break in blood 
flow may be blockage or compression of blood ves-
sels due to thrombosis, embolism or systemic hypo-
perfusion. Therapy administered in cases of acute 
ischemic stroke includes intravenous thrombolytic 
therapy – recombined tissue activator of plasminogen 
within 180, i.e. 270 minutes of the stroke.
Aim. To determine the quality of outcomes as re-
gards patient care after administering thrombolytic 
therapy in a display of progress notes of patients’ 
condition during their stay in the hospital, both be-
fore and after administering thrombolytic therapy.
Methods. A retrospective study was carried out at 
the neurology department of „Dr. Ivo Pedišić“ General 
Hospital in Sisak during 43 months from January 1, 
2013 to May 31, 2017. 85 patients participated in 
the study. Data were obtained from one component 
of nursing documentation in electronic form, namely 
progress notes on the patients’ conditions.
Results. With a 95% confidence level, a statistically 
significant difference (p<0.05) was found for parame-
ters of hygiene, feeding, elimination, dressing, walking, 
moving, sitting, standing, turning, nutrition - diet, strain 
tolerance, Braden scale and categorization, before and 
after thrombolytic therapy. Statistical significance was 
not found in the parameters of pain (p=0.067), GCS/
Trauma score scale (p=0.339), risk of fall (p=0.072).
Conclusion. The implementation of the healthcare 
process, continued monitoring of the patient’s con-
dition and progress, as well as validation of nursing 
activities provide an imperative for the application 
of nursing documentation as an essential tool in de-
scribing regular nursing activities. Application of doc-
umentation enables a more permanent insight into 
a patient’s general state, data availability, care con-
tinuity, progress chronology and result evaluation, 
as well as a material background for professional, 
expert and scientific development of nurses through 
studies in the field of nursing.
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surrounding it. According to localization, we can dif-
ferentiate bleeding within the cerebral parenchyma 
when smaller arteries are prone to arteriosclerosis 
and epidural, subdural and subarachnoid bleeding 
(11). Stroke is a multi-factor condition caused by a 
combination of vascular risk factors, the environment 
and genetic predisposition. Stroke risk factors can be 
divided into those we have the capacity to influence 
and those we cannot control (12,13). Stroke presents 
a medical emergency. Therapy administered in cases 
of acute ischemic stroke includes intravenous throm-
bolytic therapy – recombined tissue plasminogen ac-
tivator within 180, i.e. 270 minutes of the stroke and 
under the condition it meets the criteria of NIHSS 
(National Institute of Health Stroke Score) (14-17). 
Plasmin is an enzyme which dissolves fibrin, a protein 
which constitutes the main part of the blood clot. In 
that way circulation is re-established and nerve cells 
dying prevented. The objective of thrombolytic ther-
apy is to re-establish circulation, i.e. reperfusion of 
the ischemic area (8). 
In June 1996 a recombined tissue plasminogen acti-
vator (rt-PA) became the first drug approved by the 
FDA (Food and Drug Administration) for the treatment 
of stroke. It has been proven that the drug is efficient 
only within the 180 minutes from the first symp-
toms, making stroke a medical emergency (18). The 
short time period to administer the drug demands a 
fast assessment of patients who are suspected of 
suffering a stroke. Two-stage research on the util-
ity of the intravenously administered thrombolytic 
therapy was completed in 1995 and in the same year 
the results were published in the National Institute 
of Neurological Disorders and Stroke, (NINDS) in the 
United States of America (19).
Both research stages included 624 respondents who 
were administered either thrombolytic therapy (0.9 
mg/ kg) or a placebo within three hours of the first 
symptoms. The research showed that the patients 
who were given thrombolytic therapy had a signifi-
cantly higher likelihood of functional independence 
with minimum or no disability within three months of 
the treatment. The share of patients with minimum 
or no disability grew from 38 percent of placebo pa-
tients to 50 percent of those administered rt-PA, in-
dicating a 12-percent increase in improved condition. 
Intracerebral haemorrhaging connected to adminis-
tering rt-PA caused a worse final outcome in only 1 
percent of all patients. In total, in every 100 patients 
treated in the first three hours, 32 had a better out-
Introduction
In a year, around 17 million people around the world 
suffer a stroke, with 6 million dying of the conse-
quences caused by a stroke. One third of all stroke 
survivors have a certain level of temporary disability 
to function independently on a daily basis, one third 
recovers and one third stays permanently disabled 
(1). As many as 1 in 6 persons aged 15-60 are at risk 
of suffering a stroke (2). Considering population’s ag-
ing, it is estimated that by 2020 stroke will be the 
leading cause of loss of health (3).
Stroke is the single largest individual cause of dis-
ability in adult population. If a person has already 
survived a stroke, it is highly likely that a potential 
second one will either be fatal or cause a high level 
of disability (4). According to statistical data, every 
year approximately 750 thousand people suffer a 
stroke in Europe, and the number is similar in the 
United States of America. Stroke is a major health 
issue, not only in developed, but also in developing 
countries (5). Stroke has been both the leading cause 
of mortality and the leading cause of disability in the 
Republic of Croatia in the last few years. Stroke is not 
only a health problem, it is also a major economic and 
socio-economic problem. In the Republic of Croatia, 
about 25 thousand people per year suffer a stroke, 
and 8 thousand die from a stroke, meaning that 
alongside coronary conditions, it is one of the leading 
causes of mortality (6). World Health Organization 
defines a stroke as “suddenly developing clinical sig-
nals of focal or global disruption of cerebral function, 
with symptoms lasting 24 hours or longer, or leading 
to death, without an evident other cause apart from 
signs of blood vessels damage” (7). 75 to 80 percent 
of all strokes are caused by a clot in blood vessels (8). 
In instances of ischemic stroke, brain circulation is 
abruptly disconnected. Causes of this break in blood 
flow may be blockage or compression of blood ves-
sels due to thrombosis, embolism or systemic hypo-
perfusion (9). The remaining 20-25 percent of cases 
of stroke are caused by various forms of blood hem-
orrhaging prompted by a rupture in one of the brain’s 
blood vessels due to high blood pressure, natural 
weakness in the wall of the blood vessels or artery-
vein malformation (10). A hemorrhaging stroke indi-
cates blood pooling within the brain tissue or areas 
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of progress notes for monitoring patients’ condition, 
this paper investigates the quality of outcomes of 
patient care after the administration of thrombolysis 
therapy. 
Methods
The retrospective study was conducted by analysing 
the electronic forms of 85 nursing notes of patients 
who were administered thrombolytic therapy. The 
study was carried out at the neurology department 
of „Dr. Ivo Pedišić“ General Hospital in Sisak from 
January 1, 2013 to May 31, 2017. The study was 
founded on the hypothesis that there is a significant 
difference in the amount of necessary nursing care 
after the administration of thrombolytic therapy.
Statistical analysis of the patient condition notes 
before and after thrombolytic therapy was carried 
out. Data gathered in the study is data of the patient 
condition notes entered into the electronic nursing 
documentation just moments before thrombolytic 
therapy was administered. Data collected for the 
needs of the study after thrombolytic therapy was 
administered relates to data entered into the elec-
tronic nursing documentation at patients’ discharge 
independently of the duration of their hospital stay. 
The patient condition notes contain the following 
parameters: hygiene, feeding, elimination, dressing, 
walking, moving, sitting, standing, turning, nutrition 
- diet, strain tolerance, Glasgow coma scale (GCS)/
Trauma score scale, Braden scale, risk of fall and 
categorization. The parameters have been assessed 
in accordance with the descriptions as listed in the 
Nursing List of the Croatian Nursing Council (26). 
The testing was conducted using the Wilcox test of 
equivalent pairs for the purpose of establishing rank-
ing values of observed groups. Nonparametric statis-
tic was selected, considering the sample <100.
The study was approved by the Ethical Committee of 
„Dr. Ivo Pedišić“ General Hospital in Sisak.
come and 3 a worse outcome (20). In a typical me-
dial cerebral arterial ischemic stroke, a person loses 2 
million nerve cells in one minute unless reperfusion 
is accomplished (21). The analysis of 3670 patients 
included in the first eight rt-PA studies provided 
clear and plausible evidence as regards dependence 
on the time of administering thrombolytic therapy. 
Treatment in the first 90 minutes increases the like-
lihood of an excellent outcome by 2.6 times, in the 
therapy window of 91-180 minutes by 1.6 times, 
and in the therapy window of 181 to 270 minutes 
1.3 times, while treatment in the 271 to 360 min-
utes does not improve outcomes in a statistically rel-
evant way. Thus, the sooner therapy is administered, 
the better the outcome for the patient (20). Patients 
who meet the criteria for rt-PA treatment within 3 
hours of the beginning of stroke should be treated 
as recommended in the guidelines from 2007. In May 
2009 and again in March 2013 the guidelines by the 
American Heart Association/ American Stroke Asso-
ciation for administering rt-PA after an acute stroke 
have been revised so as to open up the window for 
treatment from 3 to 4.5 hours with the objective of 
enabling drug administration to a greater number of 
patients (22-24). Patients who meet the condition 
should be administered rt-PA therapy as soon as pos-
sible, ideally 60 minutes upon arrival to the hospital 
(15).
The application of nursing documentation during pa-
tients’ hospitalization ensured the possibility of mon-
itoring both the quantity and quality of treatments 
administered, especially the possibility of perma-
nently monitoring a patient’s condition. Without re-
cords on nurses’ interventions it would be extremely 
difficult to evaluate healthcare and treatments during 
hospital stay. Respective parts of nursing documen-
tation provide grounds for continued care and timely 
involvement of domiciliary care and healthcare activ-
ities at home. Nursing documentation also presents 
a sum of data which can be utilized for the purposes 
of research (25). Nurses’ interventions on patients 
who had been administered thrombolytic therapy, 
apart from enabling a high level of treatment safety, 
greatly affect the quality level of patients’ condition 
during hospitalization, of which there is no previous 
evidence found in nursing research in the Republic 
of Croatia. This has been established by searching 
Hrčak, the Croatian scientific journal portal, by using 
keywords nursing documentation, outcomes, throm-
bolysis. Pursuant to analysing summary parameters 
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was determined for parameters of Walking – Before 
x̅ = 3.52, SD = 0.63 and Risk of fall – Before x̅ =3.49, SD 
= 0.77. The lowest value x̅ was determined for GCS/ 
Trauma score scale – Before where x̅ = 1.59, SD 0.62 
and Braden scale – Before where x̅ = 2.68, SD = 0.79. 
Analysis of parameter Strain tolerance – Before deter-
mined that 82.4% of patients do not tolerate strain, 
while 17.6% of patients can tolerate strain. Analysis 
of parameter Strain tolerance – After determined that 
63.5% of patients do not tolerate strain, while 36.5% 
of patients can tolerate strain. Statistical analysis of 
parameters of patient condition notes during hospi-
talization and after thrombolysis the highest value 
x̅ was determined for parameters Hygiene – After 
where x̅ = 2.71, SD 1.16; Dressing – After where x̅ = 
2.67, SD = 1.21, Walking – After where x̅ = 2.67, SD = 
1.26. The Lowest value x̅ was determined for param-
eters: GCS/Trauma score scale – After where x̅ = 1.53, 
SD = 0.72; Braden scale – After, where x̅ = 2.19, SD = 
1.03.
Table 2 demonstrates ranks and test statistics of 
differences between the first and second measure-
ments of Wilcox test. Negative ranks describe param-
eter values which at result testing after thrombolysis 
were lower than parameter values before thromboly-
Results
Statistical analysis of electronic forms of 85 nurs-
ing lists for patients who were administered throm-
bolytic therapy determined that the average age of 
patients is 67.2 years with SD =10.86 years with 
minimum age 25 and maximum age 87. Gender dis-
tribution of respondents is 61.2% of male patients 
and 38.8% female.
Analysis of the data on the total number of throm-
bolysis administered throughout the years indi-
cates that 15.3% of thrombolysis was conducted in 
2013 and 15.3% in 2014. A rise in the number of 
thrombolysis administered was noticed in 2015 and 
2016. Of the total number of thrombolysis adminis-
tered, 25.9% was administered in 2015 and as many 
as 34.1% in 2016. In the first five months of 2017 
9.4% of the total number of thrombolysis was admin-
istered, as shown in Graph 1. 
Table 1 demonstrates a statistical analysis of parame-
ters of patient condition notes during hospitalization, 
and before thrombolysis, where the highest value x̅ 
Graph 1. The number of thrombolytic therapies administered from January 2013 to May 2017
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Table 1. Descriptive statistics of patient condition notes parameters
PARAMETER N x¯ SD Min Max
Hygiene
Before 85 3.48 0.62 2 4
After 85 2.71 1.16 1 4
Feeding
Before 85 3.32 0.77 1 4
After 85 2.52 1.25 1 4
Elimination
Before 85 3.40 0.69 1 4
After 85 2.60 1.20 1 4
Dressing
Before 85 3.47 0.64 2 4
After 85 2.67 1.20 1 4
Walking
Before 85 3.52 0.62 2 4
After 85 2.67 1.25 1 4
Moving
Before 85 3.41 0.71 2 4
After 85 2.56 1.22 1 4
Sitting
Before 85 3.27 0.86 1 4
After 85 2.47 1.25 1 4
Standing
Before 85 3.48 0.68 1 4
After 85 2.62 1.23 1 4
Turning
Before 85 3.28 0.82 1 4
After 85 2.48 1.25 1 4
Nutrition/ Diet
Before 85 3.24 0.86 1 4
After 85 2.52 1.23 1 4
Strain 
tolerance
Before 85 0.18 0.38 0 1
After 85 0.36 0.48 0 1
Pain
Before 85 0.56 1.68 0 8
After 85 0.27 1.11 0 6
GCS/ Trauma 
score scale
Before 85 1.59 0.62 1 4
After 85 1.53 0.71 1 4
Braden scale
Before 85 2.68 0.79 1 4
After 85 2.19 1.02 1 4
Risk of fall
Before 85 3.49 0.76 1 4
After 85 3.67 0.73 1 4
Categorization
Before 85 3.28 0.66 2 4
After 85 2.53 1.11 1 4
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The major advantage of thrombolysis is the im-
provement in the final functional outcome through 
reperfusion and salvation of the endangered tissue. 
Intracerebral haemorrhaging, which occurs in 6% of 
patients who have noticed deterioration after the 
administration of the drug, presents a major risk (28-
31). In NINDS studies, the number of combinations 
of minor and major symptomatic intracerebral haem-
orrhaging, i.e. any clinical deteriorations which cor-
respond in time with any new intracerebral haemor-
rhaging 24 to 36 hours after the treatment was 6.4% 
with rt-PA in relation to 0.6% without rt-PA (30-32). 
Intracerebral haemorrhaging can be signalled by 
acute hypertension, headache, neurological deterio-
ration and nausea or vomiting. Other complications 
may include haemorrhaging from intravenous cath-
eters and locations of earlier vein punctions (in 30% 
of the cases) (28-30). 
Recombined tissue plasminogen activator, rt-PA, is 
administered in the dose of 0.9 mg/ kg of body mass, 
of which 10% initially as intravenous bolus and then 
the rest in a continued intravenous infusion in the 
course of one hour. Maximum drug dosage is 90 mg. 
Thrombolytic therapy has been used in the world for 
20 years. At „Dr. Ivo Pedišić“ General Hospital, throm-
bolytic therapy has been used since 2012, when 
only one patient was administered the therapy. This 
study determined that the administration of throm-
bolytic therapy is on the rise year after year. In 2013 
and 2014 there were only 13 thrombolytic thera-
pies, in 2015 22 thrombolytic therapies were admin-
istered and in 2016 as many as 29. The study also 
sis. Positive ranks describe parameter values which 
at result testing after thrombolysis were higher than 
parameter values before thrombolysis. With a 95% 
confidence level, a statistically significant difference 
(p<0.05) was found for parameters of hygiene, feed-
ing, elimination, dressing, walking, moving, sitting, 
standing, turning, nutrition - diet, strain tolerance, 
Braden scale and categorization, before and after 
thrombolytic therapy. Statistical significance was 
not found in the parameters of pain (p=0.067), GCS/
Trauma score scale (p=0.339), risk of fall (p=0.072).
By analysing the categorization of patients before 
(xˉ=3.28) and after (xˉ=2.53) thrombolytic therapy, it 
has been determined that there has been a decrease 
in the total categorization of patients, as demon-
strated in Table 3.
Discussion
The scientific recommendation of American Heart As-
sociation/ American Stroke Association: “Scientific 
reasons for including and excluding criteria for intra-
venous alteplase in acute ischemic stroke“ published 
in 2015 contains recommendations which additionally 
clarify the criteria for acceptability of rt-PA (alteplase) 
therapy in patients with acute ischemic stroke (27, 19). 
Table 3. Categorization of patients before and after thrombolytic therapy












Total 85 100.0 2.53 1.12
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ration in patients’ conditions, especially in recogniz-
ing harmful consequences of thrombolytic treatment 
(32). Nurses involved in the care of acute stroke pa-
tients must have ongoing education. The purpose 
of education is the development of skills required to 
treat patients who have suffered a stroke and expan-
sion of knowledge in line with the latest medical de-
velopments for all types of stroke (33). Baatiema and 
associates conducted a study based on a systematic 
overview of databases MEDLINE, CINAHL, Embase, 
PsycINFO, Cochrane and AMED from 1990 to 2016 
and established the main obstacles in the application 
of scientifically grounded care treatments in instanc-
es of acute stroke. Respondents in ten studies found 
in those databases were clinical healthcare workers 
in wards and units for acute stroke care. Result anal-
ysis established the major obstacles, namely poor 
work organization, limitations as regards staff com-
petences, low level of awareness and knowledge of 
the effects of the scientifically founded administra-
tion of thrombolytic therapy, as well as inadequate 
support among healthcare staff (34). Active and 
effective nursing interventions in the first hours of 
acute stroke bring about an increase in therapy ef-
ficiency, i.e. recovery and rehabilitation. Catangui and 
Roberts’s study established that nurses are vital for 
a successful thrombolytic treatment, as they ease, 
facilitate, supervise and anticipate the course of 
thrombolytic treatment. They also claim that factors 
such as communication, teamwork, making clinical 
decisions, education and security affect and contrib-
ute to the success of thrombolytic treatment (35).
The implementation of the healthcare process, con-
tinued monitoring of the patient’s condition and 
progress, as well as validation of nursing activities 
provide an imperative for the application of nursing 
documentation as an essential tool in describing reg-
ular nursing activities. Application of documentation 
enables a more permanent insight into a patient’s 
general condition, data availability, care continuity, 
progress chronology and result evaluation, as well as 
a material background for professional, expert and 
scientific development of nurses through studies in 
the field of nursing.
The major limitation of this study was the time of data 
collected after the administered thrombolytic therapy. 
More precisely, the study considered relevant only the 
data entered into the electronic nursing documenta-
tion immediately before patients’ discharge irrelevant 
of the duration of their hospital stay. Furthermore, an-
included the first five months of 2017 where throm-
bolytic therapy was administered to 8 patients. The 
average age of the patients who were administered 
thrombolytic therapy is 67.24 with standard devia-
tion of 10.865 years. Minimum age is 25 and maxi-
mum age is 87. As regards gender distribution, there 
are 61.2% of male and 38.8 % of female patients.
As already mentioned, the study was conducted by 
insight into nursing documentation in the electronic 
form – comparison of patient condition notes before 
and after thrombolytic therapy. The following param-
eters were monitored: hygiene, feeding, elimination, 
dressing, walking, moving, sitting, standing, turning, 
nutrition - diet, strain tolerance, Glasgow coma scale 
(GCS)/Trauma score scale, Braden scale, risk of fall 
and total categorization. In order to establish poten-
tial differences among these parameters, Wilcox test 
was used, which confirmed a statistically relevant 
difference in almost all parameters of patient condi-
tion notes. By analysing categorization of patients, it 
is evident that before the administration of therapy 
10 patients belonged to category II (11.8%), 41 pa-
tients to category III (48.21%) and 34 patients to 
category IV (40%). After the administration of throm-
bolytic therapy, an improvement is evident with: 18 
patients in category I (21.2%), 28 patients in catego-
ry II (32.9%), 15 patients in category III (17.6%), and 
24 patients in category IV (28.2%). When searching 
the PubMed database for keywords nursing, docu-
mentation, outcomes and thrombolysis, not a single 
study was found which used data from nursing docu-
mentation, as did the study at hand. Grabowska and 
associates carried out a year-long prospective study 
which used different scales for the assessment of 
care outcomes and determined better outcomes of 
patient care and consequently a better quality of life 
after thrombolytic treatment. Throughout the course 
of one year 53 participants were assessed for NIHSS, 
Barthel index and quality of life scale for stroke pa-
tients. Beneficial outcomes after thrombolytic treat-
ment were determined in all three scales. At hospital 
admission, 83 % of all patients had serious or mod-
erate neurological damage. 74% reported acceptable 
level of quality of life three months after thrombo-
lytic treatment and 79% 12 months after. The neu-
rological status has been significantly improved with 
the most relevant changes during hospitalization 
– after thrombolytic treatment and in the first three 
months after discharge (31). Catangui claims that 
nurses play a vital role in early detection of deterio-
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treat patients who have suffered a stroke and ex-
pansion of knowledge in line with the latest medical 
developments for all types of stroke. New challeng-
es are a good formal, but also lifelong education, as 
well as scientific research which must be grounded 
in evidence.
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prehrane – dijete, podnošenja napora, Bradenove ska-
le i kategorizacije, a prije i poslije trombolize. Stati-
stička značajnost nije utvrđena kod parametara bol 
(p = 0,067), GCS / Trauma score ljestvice (p = 0,339) 
i rizik za pad (p = 0,072).
Zaključak. Primjena procesa zdravstvene njege, kon-
tinuirano praćenje stanja bolesnika, ali i vrednovanje 
sestrinskog rada daje imperativ primjeni sestrinske 
dokumentacije kao važnom alatu za opis sestrinske 
prakse. Primjena dokumentacije omogućuje trajni 
uvid u stanje bolesnika, dostupnost podataka, konti-
nuitet skrbi, kronološki pregled i evaluaciju rezultata, 
kao i materijalnu podlogu za profesionalni, stručni i 
znanstveni razvoj medicinskih sestara kroz istraži-
vanja u sestrinstvu.
Ključne riječi: sestrinstvo, dokumentacija, ishodi, tromboliza
Sažetak
Uvod. Sestrinska dokumentacija pokazatelj je kvali-
tete zdravstvene njege. Analizom podataka, sestrin-
ska dokumentacija postaje alat u procjeni i promjeni 
kliničke prakse. Moždani udar najveći je pojedinačni 
uzrok invaliditeta kod odrasle populacije. Kod ishe-
mijskoga moždanog udara dolazi do naglog prekida 
moždane cirkulacije. Uzroci prekida cirkulacije mo-
gu biti začepljenje ili suženje krvne žile uzrokovane 
trombozom, embolijom ili sustavnom hipoperfuzijom. 
U praksi se primjenjuje terapija za akutni ishemijski 
moždani udar koja uključuje intravensku primjenu 
trombolitičke terapije – rekombiniranoga tkivnog akti-
vatora plazminogena unutar prvih 180 odnosno 270 
minuta od nastanka moždanog udara.
Cilj. Utvrditi ishode skrbi bolesnika nakon primje-
ne trombolitičke terapije prikazom sažetka praćenja 
stanja bolesnika tijekom hospitalizacije, a u vremenu 
prije i nakon primijenjene trombolize.
Metode. Retrospektivna studija provedena je na 
odjelu neurologije u Općoj bolnici „Dr. Ivo Pedišić” u 
Sisku kroz 43 mjeseca u periodu od 1. siječnja 2013. 
do 31. svibnja 2017. U provedenoj studiji sudjelovalo 
je 85 ispitanika. Podaci su prikupljeni na temelju sa-
stavnice sestrinske dokumentacije u elektroničkom 
obliku: sažetka praćenja stanja bolesnika.
Rezultati. S razinom pouzdanosti od 95  % utvrđe-
na je statistički značajna razlika (p  <  0,05) kod pa-
rametara higijene, hranjenja, eliminacije, oblačenja, 
hodanja, premještanja, sjedanja, stajanja, okretanja, 
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